Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
FH Ortho said that it won FDA 510(k) clearance for its Calcanail system designed for rear-foot fusion therapy to repair displaced intra-articular fractures of the heel.
The system is minimally invasive and uses a nail and cannulated screws to repair rear foot or heel fractures, the Mulhouse, France-based company said. Read more
Masimo said that it won CE Mark approval in the European Union for its Root patient monitoring platform with blood pressure and temperature capabilities.
The Irvine, Calif.-based company’s device is designed to allow clinicians to non-invasively measure arterial blood pressure as well as temperature while staying connected to electronic health records, Masimo said. Read more
New data from a study of Boston Scientific’s Watchman left atrial appendage closure device reports positive results in a study comparing it to warfarin, an anticoagulant drug treatment, in patients with nonvalvular atrial fibrillation.
The 2,406-patient study, published in the Journal of the American College of Cardiology, reported a lower rate of hemorrhagic strokes, unexplained and cardiovascular death and non-procedural bleeding when compared to warfarin. Read more